CBLB and neoplasm: It was recently shown that PD-L1 silencing in DC blocks up-regulation of Cbl-b in CD8+ T cells after antigen presentation resulting in hyperactive pro-inflammatory TCRhigh CD8+ T cells and accelerated anti-tumor immune responses in the EG.7 mouse tumor model (42).